Back
Boston Scientific 10K Form
Buy
68
BSX
Boston Scientific
Last Price:
$91.02
Seasonality Move:
9.56%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-01 | 10Q | BSX/Boston Scientific Quarterly |
2024-02-21 | 10K | BSX/Boston Scientific Annual |
2024-02-20 | 10K | BSX/Boston Scientific Annual |
2023-11-01 | 10Q | BSX/Boston Scientific Quarterly |
2023-08-03 | 10Q | BSX/Boston Scientific Quarterly |
2023-05-04 | 10Q | BSX/Boston Scientific Quarterly |
Receive BSX News And Ratings
See the #1 stock for the next 7 days that we like better than BSX
BSX Financial Statistics
Sales & Book Value
Annual Sales: | $14.2B |
---|---|
Cash Flow: | $698M |
Price / Cash Flow: | 71.36 |
Annual Sales: | $14.05 |
Price / Book: | 6.48 |
Profitability
EPS (TTM): | 1.21000 |
---|---|
Net Income (TTM): | $1.8B |
Gross Margin: | $9.9B |
Return on Equity: | 8.91% |
Return on Assets: | 4.94% |
Boston Scientific Earnings Forecast
Key Boston Scientific Financial Ratios
-
The Gross Profit Margin over the past 33 years for BSX is 69.49%.
-
The Selling, General & Administrative Expenses for BSX have been equal to 36.45% of Gross Profit Margin.
-
The Research & Development expenses have been 9.93% of Revenue.
-
The Interest Expense is 16.64% of Operating Income.
-
The Net Earning history of BSX is 11.19% of Total Revenues.
-
Per Share Earnings over the last 33 years have been positive in 17 years.
Boston Scientific Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Health Care Equipment & Supplies |
Sector: | Health Care |
Current Symbol: | BSX |
CUSIP: | 101137 |
Website: | bostonscientific.com |
Debt
Debt-to-Equity Ratio: | 0.53 |
---|---|
Current Ratio: | 1.48 |
Quick Ratio: | 0.85 |
Price-to-Earnings
Trailing P/E Ratio: | 85.11 |
---|---|
Forward P/E Ratio: | 32.53 |
BSX Technical Analysis vs Fundamental Analysis
Buy
68
Boston Scientific (BSX)
is a Buy
Is Boston Scientific a Buy or a Sell?
-
Boston Scientific stock is rated a BuyThe current Boston Scientific [BSX] share price is $91.07. The Score for BSX is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.